To access Week in Review archives, click here.
2/27/2026
In addition to saving money by registering early, early bird registrants have exclusive access to a pre-annual meeting interactive workshop on “Elevating Geriatric Education through Game Based Learning and Technology-Enhanced Strategies” on March 18th. This workshop will only be open to those who have already registered for #AGS26! For more information on this workshop, click here.
It's your society... Your voice matters! Cast your vote in the AGS Board Election. Polls will close on Wed., March 18th.
We sent electronic ballots to eligible voters via email on February 18th. If you didn’t receive your ballot or have questions, contact Mary Jordan Samuel at mjsamuel@americangeriatrics.org.
This week, AGS submitted comments to the Department of Health and Human Services (HHS) in response to its request for information (RFI) on accelerating the adoption and use of artificial intelligence (AI) as a part of clinical care to inform HHS-wide use of regulation, reimbursement, and research & development in the application of AI. In our response, we highlighted the most relevant and appropriate considerations for older adults in the adoption and use of AI to address the multifaceted issues related to aging. We recommended promoting hybrid AI-human systems for transparent decision-making guided by clinician and patient values and preferences, creating aging-specific ethical frameworks and governance models, and building regulatory frameworks to help mitigate age-related algorithmic bias and promote equitable AI performance across populations, among other items.
The Centers for Medicare and Medicaid Services (CMS) approved TYENNE (tocilizumab-aazg) for the treatment of COVID-19 in hospitalized adults who get systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation. Effective April 1, 2026, CMS established HCPCS code Q0238 to describe TYENNE to treat COVID-19 and the associated administrative HCPCS codes M0233 (infusion and post administration monitoring, first dose) and M0234 (infusion and post administration monitoring, second dose). Learn more in the Medicare Learning Network (MLN) Matters article. For more information on “Not Otherwise Classified” COVID-19 monoclonal antibody product HCPCS codes, see the October 2025 update.
AGS Fellow Status (AGSF) is awarded to AGS members who have demonstrated a professional commitment to geriatrics, contributed to the progress of geriatrics care, and are active participants in the Society's activities. Fellows have distinguished themselves among their colleagues, as well as in their communities and in the Society by their service. Their dedication and longstanding commitment to AGS is recognized by this mark of distinction.
Click here to learn more and apply today!
PCORI is seeking individuals with a range of knowledge and experience to help shape and guide its research funding priorities for four multidisciplinary advisory panels:
- Comparative Clinical Effectiveness Research Advisory Panel
- Clinical Trials Advisory Panel
- Rare Disease Advisory Panel
- Patient Engagement Advisory Panel
Your unique perspective — shaped by professional expertise, personal experiences or both — can help guide the future of PCORI’s patient-centered comparative clinical effectiveness research.
If you missed the Applicant Town Hall or want to review insights on the application process, watch the replay on PCORI’s website. Apply by March 6.
The AGS Opportunities for Investigators resource serves as a central location for geriatrics and aging-related opportunities such as grant funding, presentation or publication submissions, travel stipends for scholarly meetings, networking events, comment periods, and in-person or virtual meetings and webinars. A few opportunities we'd like to include are:
- The Network for Investigation of Delirium: Unifying Scientists is accepting applications for the 2026 NIDUS Boot Camp now through April 6th. The over-arching goal of the Boot Camp is developing a multidisciplinary pipeline of well-trained translational, epidemiologic, and clinical delirium researchers.
- The Alzheimer’s Association Center for Dementia Respite Innovation will award up to $20 million in competitive grants to local respite care providers to improve and increase the delivery of person-centered dementia care, with a focus on innovation, collaboration, outcomes, accessibility, affordability and sustainability. Applications are being accepted through April 25th.
The Patient-Centered Outcomes Research Institute (PCORI) seeks to fund projects that address important methodological gaps and lead to improvements in the strength and quality of evidence generated by CER studies. Applications will be accepted through April 28th. Click here to read the full RFA
The MyAGSOnline Events Calendar is a valuable resource to discover and register for upcoming events, webinars, and other opportunities. A few upcoming events we'd like to highlight are:
- Join Geri-a-FLOAT for their latest webinar, Artificial Intelligence Part 2 on March 6th at 12pm ET / 9am PT. View all upcoming Geri-a-FLOAT webinars here.
- Join the Moving Forward Coalition's Coalition Conversations latest webinar in their series, Strengthening Nursing Home Leadership, on March 12th from 4-5pm EDT to hear key lessons from the project's mixed-methods evaluation.
Have an opportunity or event you'd like to see listed? Email the details to Jennifer Fisher at jfisher@americangeriatrics.org